Named Patient Program in India (CDSCO)
The Named Patient Program approval process is designed to provide patients with access to investigational drugs that are not yet approved
!->
!->Deep dive and engage in insightful discourse driven by concurrent global regulatory scenarios, industry trends and Artixio’s real-time experience across the product value chain. Whitepapers, research articles, landscape reports and case studies to help you stay ahead of the curve.